SCHEMBL3277310

SCHEMBL3277310

NNc1ccc2c(=O)[nH][nH]c(=O)c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ BRAF P15056 2/20 0.39
▸ DAO P14920 2/20 0.38
▸ METAP2 P50579 1/20 0.38
▸ PARP15 Q460N3 4/20 0.38
▸ PARP10 Q53GL7 4/20 0.38
▸ TDP1 Q9NUW8 2/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ DAPK3 O43293 1/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ PRKD3 O94806 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953743 0.80 PIK3CD (0.40) HSD17B10KDM4EBRAFDAOMETAP2
SCHEMBL7070839 0.79 KDM4E (0.50) HSD17B10KDM4EBRAFDAOMETAP2
SCHEMBL8691865 0.76 KDM4E (0.43) HSD17B10KDM4EBRAFDAOMETAP2
SCHEMBL17142230 0.76 KDM4E (0.43) HSD17B10KDM4EBRAFDAOMETAP2
SCHEMBL3069941 0.76 PIK3CD (0.47) HSD17B10KDM4EDAOPARP15PARP10
SCHEMBL438637 0.75 AR (0.47) HSD17B10KDM4EBRAFPARP15PARP10
SCHEMBL7072330 0.75 BRAF (0.58) HSD17B10KDM4EBRAFTDP1PIK3CD
SCHEMBL6955664 0.75 IP6K1 (0.43) KDM4EPIK3CD
SCHEMBL5312181 0.74 KDM4E (0.40) KDM4EDAOTDP1NPC1POLB
SCHEMBL11262249 0.73 PIK3CD (0.36) HSD17B10KDM4EBRAFPARP15PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4448715-A Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1984-05-15 — — US claimed
EP-0078703-A2 New tagged pyroglu-l-phe-l-arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1983-05-11 — — EP claimed
US-7700304-B2 Methods of screening disorders related to apoE THE J. DAVID GLADSTONE INSTITUTES (US) 2010-04-20 — — US disclosed
EP-1443816-B1 METHODS OF TREATING DISORDERS RELATED TO APOE DAVID GLADSTONE INST (US) 2008-06-11 — — EP disclosed
US-7108988-B2 Methods of identifying agents for inhibiting lentivirus replication THE J. DAVID GLADSTONE INSTITUTES (US) 2006-09-19 — — US disclosed
US-20040268423-A1 Methods of treating disorders related to apoE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-12-30 — — US disclosed
US-6787519-B2 REDUCING NEURONAL TANGLES IN ALZHEMIER'S PATIENTS; OBTAIN HUMAN, ADMINISTER MODULATOR, MONITOR DEVELOPMENT OF NEURONAL TANGLES IN, REDUCTION IN NEURONAL TANGLES INDICATES MODULATOR THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-09-07 — — US disclosed
US-20040009909-A1 Methods for inhibiting lentivirus replication NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-01-15 — — US disclosed
US-20020147999-A1 Methods of treating disorders related to apoE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-10-10 — — US disclosed
US-6235494-B1 USING CHELATE COMPOUND THE SCRIPPS RESEARCH INSTITUTE 2001-05-22 — — US disclosed
US-4448715-A Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1984-05-15 — — US disclosed
EP-0078703-A2 New tagged pyroglu-l-phe-l-arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1983-05-11 — — EP disclosed
Send feedback